Fort Washington Investment Advisors Reduces Stake in Bio-Techne

The institutional investor sold over 146,000 shares of the biotechnology company in Q4 2025.

Mar. 28, 2026 at 8:08am

Got story updates? Submit your updates here. ›

Fort Washington Investment Advisors Inc. OH decreased its position in shares of Bio-Techne Corp (NASDAQ:TECH) by 30.9% in the 4th quarter, according to the company's latest SEC filing. The institutional investor now owns 327,553 shares of the biotechnology company's stock, worth approximately $19.3 million.

Why it matters

This filing provides insight into the investment strategy and portfolio changes of Fort Washington Investment Advisors, a major institutional investor in the biotechnology sector. The reduction in Bio-Techne holdings could signal a shift in the firm's outlook on the company or the broader industry.

The details

Fort Washington Investment Advisors sold 146,767 shares of Bio-Techne in the fourth quarter, reducing its overall stake in the company by nearly a third. The firm now owns about 0.21% of Bio-Techne's outstanding shares. Other large investors, including Goldman Sachs and JPMorgan Chase, have also made changes to their Bio-Techne positions in recent quarters.

  • The share sale occurred in the 4th quarter of 2025.
  • Fort Washington Investment Advisors filed the 13F report disclosing the transaction on March 28, 2026.

The players

Fort Washington Investment Advisors Inc. OH

A major institutional investor and asset management firm based in Ohio.

Bio-Techne Corp

A publicly traded biotechnology company that develops and manufactures high-quality reagents, instruments, and services for the research, diagnostic, and bioprocessing markets.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the ongoing shifts in institutional investment within the biotechnology sector, as firms like Fort Washington Investment Advisors rebalance their portfolios in response to market conditions and their own strategic priorities.